Published in Radiother Oncol on August 01, 2003
The effect of fraction time in intensity modulated radiotherapy: theoretical and experimental evaluation of an optimization problem (the real conclusions): in regard to Mu et al. Radiotherapy on Oncology 2003; 68: 181-87. Radiother Oncol (2004) 1.07
A fast radiotherapy paradigm for anal cancer with volumetric modulated arc therapy (VMAT). Radiat Oncol (2009) 1.02
Magnetic resonance imaging for adaptive cobalt tomotherapy: A proposal. J Med Phys (2006) 0.97
The in vivo study on the radiobiologic effect of prolonged delivery time to tumor control in C57BL mice implanted with Lewis lung cancer. Radiat Oncol (2011) 0.92
A study of the biological effects of modulated 6 MV radiation fields. Phys Med Biol (2010) 0.89
Effect of prolonging radiation delivery time on retention of gammaH2AX. Radiat Oncol (2008) 0.86
Single arc volumetric-modulated arc therapy is sufficient for nasopharyngeal carcinoma: a dosimetric comparison with dual arc VMAT and dynamic MLC and step-and-shoot intensity-modulated radiotherapy. Radiat Oncol (2013) 0.84
The Cell Survival of F10B16 Melanoma and 4T1 Breast Adenocarcinoma Irradiated to Gamma Radiation Using the MTT Assay Based on Two Different Calculation Methods. J Biomed Phys Eng (2013) 0.83
A dosimetric comparison of volumetric modulated arc therapy (VMAT) and non-coplanar intensity modulated radiotherapy (IMRT) for nasal cavity and paranasal sinus cancer. Radiat Oncol (2014) 0.82
In vitro and in vivo studies on radiobiological effects of prolonged fraction delivery time in A549 cells. J Radiat Res (2012) 0.81
Curcumin decreases survival of Hep3B liver and MCF-7 breast cancer cells: the role of HIF. Strahlenther Onkol (2011) 0.80
Image-Guided Radiotherapy Using a Modified Industrial Micro-CT for Preclinical Applications. PLoS One (2015) 0.79
In vitro effects of Cyberknife-driven intermittent irradiation on glioblastoma cell lines. Neurol Sci (2011) 0.79
Rad51 in regulating the radiosensitivity of non-small cell lung cancer with different epidermal growth factor receptor mutation status. Thorac Cancer (2015) 0.78
Late-responding normal tissue cells benefit from high-precision radiotherapy with prolonged fraction delivery times via enhanced autophagy. Sci Rep (2015) 0.78
Comparison of simple and complex liver intensity modulated radiotherapy. Radiat Oncol (2010) 0.75
Correlation between dose subfractions: in regard to Tome et al. [Radiother Oncol 2004;72:113-114]. Radiother Oncol (2005) 0.75
Estimation of cell response in fractionation radiotherapy using different methods derived from linear quadratic model. Radiol Oncol (2015) 0.75
The changing paradigm of tumour response to irradiation. Br J Radiol (2016) 0.75
CT substitute derived from MRI sequences with ultrashort echo time. Med Phys (2011) 1.84
Comparison between a conventional treatment energy and 50 MV photons for the treatment of lung tumours. Phys Med Biol (2002) 1.39
Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study. Acta Oncol (2005) 1.22
Treatment planning using MRI data: an analysis of the dose calculation accuracy for different treatment regions. Radiat Oncol (2010) 1.21
Dedicated magnetic resonance imaging in the radiotherapy clinic. Int J Radiat Oncol Biol Phys (2009) 1.18
Systematisation of spatial uncertainties for comparison between a MR and a CT-based radiotherapy workflow for prostate treatments. Radiat Oncol (2009) 1.13
Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases. Int J Radiat Oncol Biol Phys (2005) 1.04
The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties. Free Radic Biol Med (2010) 1.03
The use of risk estimation models for the induction of secondary cancers following radiotherapy. Acta Oncol (2005) 1.02
Theoretical simulation of tumour oxygenation and results from acute and chronic hypoxia. Phys Med Biol (2003) 1.02
Cell cycle disturbances and mitotic catastrophes in HeLa Hep2 cells following 2.5 to 10 Gy of ionizing radiation. Clin Cancer Res (2007) 1.02
Evaluation of an attenuation correction method for PET/MR imaging of the head based on substitute CT images. MAGMA (2012) 1.01
Number of patients potentially eligible for proton therapy. Acta Oncol (2005) 0.99
Large aggregates are the major soluble Aβ species in AD brain fractionated with density gradient ultracentrifugation. PLoS One (2012) 0.96
The effects of hypoxia on the theoretical modelling of tumour control probability. Acta Oncol (2005) 0.95
Variability in prostate and seminal vesicle delineations defined on magnetic resonance images, a multi-observer, -center and -sequence study. Radiat Oncol (2013) 0.92
Apoptosis induced by low-dose and low-dose-rate radiation. Cancer (2002) 0.92
Voxel-wise uncertainty in CT substitute derived from MRI. Med Phys (2012) 0.91
Hypofractionated conformal stereotactic radiotherapy for arteriovenous malformations. Neurosurgery (2003) 0.91
Weight and body mass index in relation to irradiated volume and to overall survival in patients with oropharyngeal cancer: a retrospective cohort study. Radiat Oncol (2014) 0.90
Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage. Gynecol Oncol (2004) 0.89
Recombinant erythropoietin beta enhances growth of xenografted human squamous cell carcinoma of the head and neck after surgical trauma. Acta Otolaryngol (2006) 0.88
Radiation-induced trismus in the ARTSCAN head and neck trial. Acta Oncol (2014) 0.86
Weight loss in patients with head and neck cancer during and after conventional and accelerated radiotherapy. Acta Oncol (2012) 0.85
Clinical evaluation of monitor unit software and the application of action levels. Radiother Oncol (2007) 0.85
Combined low dose radio- and radioimmunotherapy of experimental HeLa Hep 2 tumours. Eur J Nucl Med Mol Imaging (2003) 0.85
Biological response to radiation therapy. Acta Oncol (2003) 0.84
The potential of proton beam radiation therapy in head and neck cancer. Acta Oncol (2005) 0.84
Intensity modulated radiation therapy with electrons using algorithm based energy/range selection methods. Radiother Oncol (2004) 0.82
Five-year prospective patient evaluation of bladder and bowel symptoms after dose-escalated radiotherapy for prostate cancer with the BeamCath technique. Int J Radiat Oncol Biol Phys (2006) 0.81
A comparison between surgical resection in combination with WBRT or hypofractionated stereotactic irradiation in the treatment of solitary brain metastases. Acta Neurochir (Wien) (2009) 0.80
Coping with complexity in baltic sea risk governance: introduction. Ambio (2011) 0.80
The quality assurance process for the ARTSCAN head and neck study - a practical interactive approach for QA in 3DCRT and IMRT. Radiother Oncol (2008) 0.80
Daily-diary evaluated side effects of dose-escalation radiotherapy of prostate cancer using the stereotactic BeamCath technique. Acta Oncol (2003) 0.79
Weight loss and body mass index in relation to aspiration in patients treated for head and neck cancer: a long-term follow-up. Support Care Cancer (2014) 0.79
Apoptotic signalling in HeLa Hep2 cells following 5 Gy of cobalt-60 gamma radiation. Anticancer Res (2009) 0.79
Erythropoietin therapy and cancer related anaemia: updated Swedish recommendations. Med Oncol (2007) 0.78
Telemedicine as a tool for sharing competence in paediatric radiotherapy: implementation and initial experiences from a Swedish project. Acta Oncol (2009) 0.78
Can photon IMRT be improved by combination with mixed electron and photon techniques? Acta Oncol (2004) 0.78
1-[11C]-acetate PET imaging in head and neck cancer--a comparison with 18F-FDG-PET: implications for staging and radiotherapy planning. Eur J Nucl Med Mol Imaging (2006) 0.78
Reproducibility and geometric accuracy of the Fixster system during hypofractionated stereotactic radiotherapy. Radiat Oncol (2008) 0.78
Iodine-131 induces mitotic catastrophes and activates apoptotic pathways in HeLa Hep2 cells. Cancer Biother Radiopharm (2008) 0.78
The lipid peroxidation metabolite 4-oxo-2-nonenal cross-links alpha-synuclein causing rapid formation of stable oligomers. Biochem Biophys Res Commun (2008) 0.78
A novel estimation method for physiological parameters in dynamic contrast-enhanced MRI: application of a distributed parameter model using Fourier-domain calculations. IEEE Trans Med Imaging (2009) 0.78
The relationship between temporal variation of hypoxia, polarographic measurements and predictions of tumour response to radiation. Phys Med Biol (2004) 0.78
Designed protein binders in combination with nanocrystalline diamond for use in high-sensitivity biosensors. Anal Bioanal Chem (2012) 0.77
Off-pathway α-synuclein oligomers seem to alter α-synuclein turnover in a cell model but lack seeding capability in vivo. Amyloid (2013) 0.77
Effects of inflow and radiofrequency spoiling on the arterial input function in dynamic contrast-enhanced MRI: a combined phantom and simulation study. Magn Reson Med (2011) 0.77
[Distance pediatric radiotherapy. Telemedicine a good tool to be used for discussions, exchange of experiences and competence]. Lakartidningen (2006) 0.77
Registration accuracy for MR images of the prostate using a subvolume based registration protocol. Radiat Oncol (2011) 0.77
Optimization of photon beam flatness for radiation therapy. Phys Med Biol (2007) 0.77
Diamonds are a spectroscopist's best friend: thin-film diamond mid-infrared waveguides for advanced chemical sensors/biosensors. Anal Chem (2014) 0.77
Evaluation of uncertainty predictions and dose output for model-based dose calculations for megavoltage photon beams. Med Phys (2006) 0.76
Theoretical simulation of tumour hypoxia measurements. Adv Exp Med Biol (2006) 0.76
Liquid ionization chamber calibrated gel dosimetry in conformal stereotactic radiotherapy of brain lesions. Acta Oncol (2008) 0.76
A widely tested model for head scatter influence on photon beam output. Radiother Oncol (2003) 0.76
Stroke asymmetry of tilted superhydrophobic ion track textures. Langmuir (2010) 0.76
The combination of external beam radiotherapy and experimental radioimmunotargeting with a monoclonal anticytokeratin antibody. Cancer (2002) 0.76
Patient-specific IMRT verification using independent fluence-based dose calculation software: experimental benchmarking and initial clinical experience. Phys Med Biol (2007) 0.76
Phase-based arterial input functions in humans applied to dynamic contrast-enhanced MRI: potential usefulness and limitations. MAGMA (2011) 0.76
Inclined surfaces in diamond: broadband antireflective structures and coupling light through waveguides. Opt Express (2013) 0.76
Dose uncertainties in photon pencil kernel calculations at off-axis positions. Med Phys (2006) 0.75
Photon and electron collimator effects on electron output and abutting segments in energy modulated electron therapy. Med Phys (2005) 0.75
Diamond-based dielectric laser acceleration. Opt Express (2022) 0.75
Uncertainty estimation in dynamic contrast-enhanced MRI. Magn Reson Med (2012) 0.75
On empirical methods to determine scatter factors for irregular MLC shaped beams. Med Phys (2004) 0.75
Radiation therapy dose delivery. Acta Oncol (2003) 0.75
Conversion of polarographic electrode measurements--a computer based approach. Phys Med Biol (2005) 0.75
Prospective evaluation of urinary and intestinal side effects after BeamCath stereotactic dose-escalated radiotherapy of prostate cancer. Radiother Oncol (2002) 0.75
Pencil kernel correction and residual error estimation for quality-index-based dose calculations. Phys Med Biol (2006) 0.75
Fabrication and evaluation of a diamond diffractive fan-out element for high power lasers. Opt Express (2003) 0.75
Gelsolin co-occurs with Lewy bodies in vivo and accelerates α-synuclein aggregation in vitro. Biochem Biophys Res Commun (2011) 0.75
Photon pencil kernel parameterisation based on beam quality index. Radiother Oncol (2006) 0.75
Multileaf collimation of electrons--clinical effects on electron energy modulation and mixed beam therapy depending on treatment head design. Phys Med Biol (2002) 0.75
Design, manufacturing, and performance analysis of mid-infrared achromatic half-wave plates with diamond subwavelength gratings. Appl Opt (2012) 0.75
[Joint Center--a collaboration project for optimal decentralized radiotherapy]. Lakartidningen (2004) 0.75
Diamond micro-optics: microlenses and antireflection structured surfaces for the infrared spectral region. Opt Express (2003) 0.75
"Distributed proton radiation therapy"--a new concept for advanced competence support. Acta Oncol (2006) 0.75
Electron beam collimation with focused and curved leaf end MLCs--experimental verification of Monte Carlo optimized designs. Med Phys (2002) 0.75
A practical method to calculate head scatter factors in wedged rectangular and irregular MLC shaped beams for external and internal wedges. Phys Med Biol (2004) 0.75
Natural Mineral-Based Solid Oxide Fuel Cell with Heterogeneous Nanocomposite Derived from Hematite and Rare-Earth Minerals. ACS Appl Mater Interfaces (2016) 0.75
Swedish Cancer Society radiation therapy research investigation. Acta Oncol (2002) 0.75
Effects on electron beam penumbra using the photon MLC to reduce bremsstrahlung leakage for an add-on electron MLC. Phys Med Biol (2005) 0.75
Interactions between chemotherapy, endocrine therapy and radiation. Acta Oncol (2002) 0.75